UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stake in Merit Medical Systems, Inc. $MMSI

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 11.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 173,854 shares of the medical instruments supplier’s stock after acquiring an additional 18,276 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.29% of Merit Medical Systems worth $12,055,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in MMSI. Los Angeles Capital Management LLC bought a new position in Merit Medical Systems during the 4th quarter worth about $25,000. Kilter Group LLC purchased a new position in Merit Medical Systems during the second quarter valued at approximately $25,000. Covestor Ltd increased its holdings in Merit Medical Systems by 252.6% during the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 336 shares during the period. Danske Bank A S bought a new position in Merit Medical Systems in the third quarter worth approximately $42,000. Finally, Quarry LP lifted its holdings in Merit Medical Systems by 185.9% during the third quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock worth $44,000 after buying an additional 342 shares during the period. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Stock Performance

Shares of NASDAQ:MMSI opened at $89.60 on Monday. The company has a current ratio of 4.20, a quick ratio of 2.79 and a debt-to-equity ratio of 0.44. Merit Medical Systems, Inc. has a 12-month low of $59.74 and a 12-month high of $94.75. The business has a 50 day moving average of $81.85 and a two-hundred day moving average of $73.16. The company has a market capitalization of $5.35 billion, a PE ratio of 37.02, a PEG ratio of 2.24 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.23. Merit Medical Systems had a net margin of 9.22% and a return on equity of 13.75%. The business had revenue of $418.84 million for the quarter, compared to analysts’ expectations of $405.25 million. During the same quarter last year, the company earned $1.01 EPS. The business’s revenue was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, analysts forecast that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

Analysts Set New Price Targets

Several research firms have commented on MMSI. Piper Sandler increased their price target on shares of Merit Medical Systems from $96.00 to $106.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Zacks Research raised Merit Medical Systems from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 25th. Raymond James Financial reiterated an “outperform” rating and issued a $100.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. Canaccord Genuity Group raised their price target on shares of Merit Medical Systems from $85.00 to $94.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Finally, Weiss Ratings upgraded shares of Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, August 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $100.00.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.